Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

House dust mite allergy immunotherapy tablet - Stallergenes Greer plc

Next Previous
Search
Drug Profile

House dust mite allergy immunotherapy tablet - Stallergenes Greer plc

Alternative Names: ACTAIR; Actair; Aitmyte; House dust mite allergy immunotherapy - Stallergenes Greer plc; House dust mite SLIT; House dust mite sublingual immunotherapy; Oralair Mites; Orlymyte; ORYLMYTE; Orylmyte; S-524101; STAGR 320; STG 320

Latest Information Update: 06 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Stallergenes SA
  • Developer Shionogi; Stallergenes Greer plc
  • Class Allergens; Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic asthma; Perennial allergic rhinitis

Most Recent Events

  • 26 Jun 2024 Launched for Perennial allergic rhinitis (In adolescents, In adults) in Austria (Sublingual) before June 2024
  • 26 Jun 2024 Launched for Perennial allergic rhinitis (In adolescents, In adults) in Bulgaria (Sublingual)
  • 26 Jun 2024 Launched for Perennial allergic rhinitis (In adolescents, In adults) in Croatia (Sublingual) before June 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top